SCHEMBL7096162

SCHEMBL7096162

CCN(C(=O)C1CC(Oc2cc(-c3ccccc3)nc3cc(OC)ccc23)CN1)C1CC1C(=O)OC

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ALDH1A1 P00352 2/20 0.44
TACR3 P29371 8/20 0.41
PLA2G2A P14555 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
CTSB P07858 1/20 0.38
NQO2 P16083 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
NPC1 O15118 1/20 0.36
MITF O75030 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
PAX8 Q06710 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617427 0.86 KDM4E (0.55) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL8354904 0.86 KDM4E (0.55) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL3052280 0.82 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL4981224 0.82 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL5692604 0.82 KDM4E (0.57) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL7095755 0.82 KDM4E (0.51) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL8203094 0.81 KDM4E (0.55) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL13668748 0.78 TACR3 (0.46) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL13451792 0.78 TACR3 (0.46) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A
SCHEMBL13451464 0.77 KDM4E (0.48) KDM4ESMN1; SMN2ALDH1A1TACR3PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337550-A2 HEPATITIS C TRIPEPTIDE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-08-27 EP disclosed
WO-2002060926-A2 HEPATITIS C TRIPEPTIDE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2002-08-08 WO disclosed